Boston CEO
November 2-3, 2026
Mandarin Oriental Hotel, Boston
Co-hosted with leaders in the industry, join Longwood Healthcare Leaders this fall as top BioPharma executives convene for off-the-record discussions and top tier networking with BioPharma CEOs, heads of research and development, life science investors, and leading academics.
Highlights
Boston CEO is co-hosted with leaders in the industry. See testimonials and highlights from speakers and attendees including MA Governor Maura Healey, Boston Mayor Michelle Wu, George Yancopoulos (CSO, Regeneron), Fiona Marshall (President, NIBR), Sally Kornbluth (President, MIT), Robert Plenge (Chief Research Officer, BMS), among others.
Longwood Healthcare Leaders Boston CEO 2025
Longwood Healthcare Leaders Boston CEO 2025
Longwood Healthcare Leaders Boston CEO 2024
Boston CEO Co-Hosts
Boston CEO is co-hosted alongside leaders in the industry.
Current & Former Speakers
Celebrated Academics
World-Class BioPharma CEOs
Renowned Researchers
Biotech Luminaries
Top Strategy Executives
Key Current & Former Government Officials
Blue-Chip Investors
Venue
Longwood Healthcare Leaders Boston CEO
is held at the Mandarin Oriental, Boston
2nd Floor Ballroom
776 Boylston St, Boston, MA 02199
617-535 8888
2026 Agenda
Monday, November 2, 2026
7:00 am | Networking Breakfast
7:40 am | Biotech Market Update & Longwood Fund Introduction
Christoph Westphal, General Partner, Longwood Fund
8:00 am | Translating Science into Medicine
Laurent Levy, CEO, Nanobiotix
Kia Motesharei, President & COO ReAlta Life Sciences
Brendan Smith, CEO, Weaver Biosciences
8:30 am | Ecosystem of External Innovation
Nadim Ahmed, CEO, Cullinan Therapeutics
Anne Klibanski, CEO, Mass General Brigham
9:00 am | Developing a Robust Pipeline
Giulio Draetta, Chief Strategy Officer, Orionis
Jason Luke, CMO, Strand Therapeutics
9:30 am | Fireside Chat
Phil Sharp, Nobel laureate; Co-Founder, Alnylam/Biogen
Moderator: Christoph Westphal, Founder/CEO/Lead Investor, Alnylam
9:50 am | Networking Break
10:20 am | R&D Collaboration
Brad Margus, Chair, Cerevance
Benjamin Moutier, SVP, Infectious Disease, AstraZeneca
Stef van Grieken, CEO, Cradle Bio
10:50 am | Delivering the Next Generation of Diagnostics
Julian Adams, CEO, Stand Up To Cancer
Bharat Tewarie, CEO, Helio Genomics
11:20 am | Competing in a New Global Playing Field
Raj Prasad, CFO, Crispr Therapeutics
11:50 am | Gubernatorial Keynote
12:10 pm | Networking Luncheon
1:00 pm | Fireside Chat
Bob Langer, Koch Institute Professor, MIT; Co-Founder, Moderna
1:20 pm | Leveraging an Effective Board
Bill Heiden, Chair, Macrogenics
Tim Noyes, CEO, Newleos
Rob Perez, Chair, Life Science Cares
Mike Rosenblatt, Senior Advisor, Flagship Pioneering; former CMO, Merck
Catherine Sohn, Director, Altimmune
1:50 pm | Biopharma Pipeline Sourcing
2:20 pm | Driving Productivity in R&D
Manuel Aivado, CEO, Stelexis
Rachel Humphrey, CEO, Normunity
Yiannis Kiachopoulos, CEO, Causaly
2:50 pm | Networking Break
3:10 pm | Bolstering the Regulatory Strategy
Peter Hutt, former General Counsel, FDA
3:40 pm | Capital Formation and Strategic Partnerships
Jeff Aronin, CEO, Paragon Biosciences
Sean McCarthy, CEO, CytomX
Tim Ehrlich, Partner, Gunderson Dettmer
4:10 pm | Fireside Chat
4:30 pm | Investor Outlook
Raymond Kelleher, Managing Director, Cormorant
Tuesday, November 3, 2026
7:00 am | Networking Breakfast
7:40 am | Biotech Market Update & Longwood Fund Introduction
Christoph Westphal, General Partner, Longwood Fund
8:00 am | Building Global BioPharmas
Pedro Lichtinger, CEO, Starton Therapeutics
Richard Paulson, CEO, Karyopharm
8:30 am | Drug Approvals: Insights, Outlook, and Commitment to Patients
Annette Bakker, CEO, Children's Tumor Foundation
Jean-Frédéric Paulsen, CEO, Ferring Pharmaceuticals
9:00 am | Crossroads of Science and Policy: Sustaining the Engine of Innovation
Susan Hockfield, President Emerita, MIT
John O’Brien, CEO, National Pharmaceutical Council
Tarek Rabah, CEO, Otsuka North America
9:30 am | Fireside Chat
Jeff Legos, Chief Oncology Officer, Pfizer
Robert Plenge, Chief Research Officer, BMS
9:50 am | Networking Break
10:20 am | Prioritizing the Pipeline
Marion Dorsch, CSO, Atavistik Bio
Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation, Astellas
10:50 am | Advancing Late-Stage Assets
Abe Ceesay, CEO, Rapport Therapeutics
Robert Stanislaro, Senior Managing Director, FTI Consulting
11:20 am | Managing the Runway
Chris Loose, CEO, Progentos
Bart van Rijn, CFO, Nanobiotix
Brent Vaughan, CEO, Eratos Therapeutics
Moderator: Rick Lundberg, CEO, Eikonizo
11:50 am | Fireside Chat
Mathai Mammen, CEO, Parabilis
Stefan Oelrich, CEO, Bayer Pharmaceuticals
12:10 pm | Networking Luncheon
1:00 pm | Fireside Chat: Pharma R&D
Fiona Marshall, President, BioMedical Research, Novartis
David Weinreich, Global Head, R&D, EMD Serono
Moderator: Sekhar Naik, CEO, MResult
1:25 pm | Targeted Licensing & Acquisitions
Jeff Landau, CEO, Stipple Bio
Zhen Su, CEO, Marengo Therapeutics
2:55 pm | Accelerating Drug Discovery
Aris Baras, SVP, Co-Head, Regeneron Genetic Medicines
Jacob Hooker, CEO, Sensorium Therapeutics
Szabi Nagy, CEO, Turbine
Phil Vickers, CEO, Solu Therapeutics
2:20 pm | Fireside Chat
2:40 pm | Positioning for Commercial Success
Vikram Karnani, CEO, Collegium Pharmaceutical
Kabir Nath, CEO, COMPASS Pathways
Karin Shanahan, EVP, Chief Supply Chain & Operations Officer, BMS
3:10 pm | Networking Breaks
3:40 pm | Fireside Chat
Patrizia Cavazzoni, CMO, Pfizer; former Director, CDER, FDA
4:00 pm | The Evolving Deal-Making Landscape
Philippe Lopes-Fernandes, CBO, Ipsen
Issei Tsukamoto, SVP, Head, BD, Astellas
4:30 pm | Evaluating Investment Risk
Ari Brettman, Senior Managing Director, Blackstone Life Science
Ansbert Gadicke, Managing Partner, MPM BioImpact
Pini Orbach, Managing Partner & Head, Pharma, Arkin Capital
5:00 pm | Cocktail Reception
Speaking Faculty
